<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB03256</drugbank-id>
  <drugbank-id>EXPT01470</drugbank-id>
  <name>(6R)-Folinic acid</name>
  <description/>
  <cas-number>73951-54-9</cas-number>
  <unii/>
  <average-mass>473.4393</average-mass>
  <monoisotopic-mass>473.165896125</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</description>
    <direct-parent>Glutamic acid and derivatives</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic acids and derivatives</superclass>
    <class>Carboxylic acids and derivatives</class>
    <subclass>Amino acids, peptides, and analogues</subclass>
    <alternative-parent>Amino acids</alternative-parent>
    <alternative-parent>Aminobenzamides</alternative-parent>
    <alternative-parent>Aniline and substituted anilines</alternative-parent>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Benzoyl derivatives</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Dicarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hippuric acids</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Hydroxypyrimidines</alternative-parent>
    <alternative-parent>N-acyl-alpha amino acids</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Phenylalkylamines</alternative-parent>
    <alternative-parent>Pterins and derivatives</alternative-parent>
    <alternative-parent>Secondary alkylarylamines</alternative-parent>
    <alternative-parent>Secondary carboxylic acid amides</alternative-parent>
    <alternative-parent>Tertiary carboxylic acid amides</alternative-parent>
    <substituent>Amine</substituent>
    <substituent>Amino acid</substituent>
    <substituent>Aminobenzamide</substituent>
    <substituent>Aminobenzoic acid or derivatives</substituent>
    <substituent>Aniline or substituted anilines</substituent>
    <substituent>Aromatic heteropolycyclic compound</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Benzamide</substituent>
    <substituent>Benzenoid</substituent>
    <substituent>Benzoic acid or derivatives</substituent>
    <substituent>Benzoyl</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxamide group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Dicarboxylic acid or derivatives</substituent>
    <substituent>Glutamic acid or derivatives</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hippuric acid</substituent>
    <substituent>Hippuric acid or derivatives</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Hydroxypyrimidine</substituent>
    <substituent>Monocyclic benzene moiety</substituent>
    <substituent>N-acyl-alpha amino acid or derivatives</substituent>
    <substituent>N-acyl-alpha-amino acid</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organoheterocyclic compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Phenylalkylamine</substituent>
    <substituent>Pteridine</substituent>
    <substituent>Pterin</substituent>
    <substituent>Pyrimidine</substituent>
    <substituent>Secondary aliphatic/aromatic amine</substituent>
    <substituent>Secondary amine</substituent>
    <substituent>Secondary carboxylic acid amide</substituent>
    <substituent>Tertiary carboxylic acid amide</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">(6R,2'S)-Folinic acid</synonym>
    <synonym language="english" coder="">(6R)-Leucovorin</synonym>
    <synonym language="english" coder="">[6R]-5-formyl-5,6,7,8-tetrahydrofolate </synonym>
    <synonym language="english" coder="">6R-Leucovorin</synonym>
    <synonym language="english" coder="">Dextrofolinic acid</synonym>
    <synonym language="english" coder="">L-Glutamic acid, N-[4-[[[(6R)-2-amino-5-formyl-3,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-</synonym>
    <synonym language="english" coder="">N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid</synonym>
  </synonyms>
  <products/>
  <international-brands/>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Folic Acid and Derivatives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Vitamin B Complex</category>
      <mesh-id>D014803</mesh-id>
    </category>
    <category>
      <category>Vitamins</category>
      <mesh-id>D014815</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1kl2</pdb-entry>
    <pdb-entry>1qd1</pdb-entry>
    <pdb-entry>1vrq</pdb-entry>
    <pdb-entry>1xzq</pdb-entry>
    <pdb-entry>2bln</pdb-entry>
    <pdb-entry>3gee</pdb-entry>
    <pdb-entry>3geh</pdb-entry>
    <pdb-entry>4lxq</pdb-entry>
    <pdb-entry>4lxt</pdb-entry>
    <pdb-entry>4lxu</pdb-entry>
    <pdb-entry>4lxx</pdb-entry>
    <pdb-entry>4oyt</pdb-entry>
    <pdb-entry>4xcz</pdb-entry>
    <pdb-entry>4xd0</pdb-entry>
    <pdb-entry>4xd1</pdb-entry>
    <pdb-entry>5es7</pdb-entry>
    <pdb-entry>5uik</pdb-entry>
    <pdb-entry>5uim</pdb-entry>
    <pdb-entry>5uin</pdb-entry>
    <pdb-entry>5vyq</pdb-entry>
    <pdb-entry>5vyt</pdb-entry>
    <pdb-entry>6mfw</pdb-entry>
    <pdb-entry>6nbp</pdb-entry>
  </pdb-entries>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB01320</drugbank-id>
      <name>Fosphenytoin</name>
      <description>The serum concentration of Fosphenytoin can be decreased when it is combined with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00293</drugbank-id>
      <name>Raltitrexed</name>
      <description>The therapeutic efficacy of Raltitrexed can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00795</drugbank-id>
      <name>Sulfasalazine</name>
      <description>The serum concentration of (6R)-Folinic acid can be decreased when it is combined with Sulfasalazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00252</drugbank-id>
      <name>Phenytoin</name>
      <description>The serum concentration of Phenytoin can be decreased when it is combined with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08898</drugbank-id>
      <name>Glucarpidase</name>
      <description>The serum concentration of the active metabolites of (6R)-Folinic acid can be reduced when (6R)-Folinic acid is used in combination with Glucarpidase resulting in a loss in efficacy.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01174</drugbank-id>
      <name>Phenobarbital</name>
      <description>The serum concentration of Phenobarbital can be decreased when it is combined with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00794</drugbank-id>
      <name>Primidone</name>
      <description>The serum concentration of Primidone can be decreased when it is combined with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00205</drugbank-id>
      <name>Pyrimethamine</name>
      <description>The therapeutic efficacy of Pyrimethamine can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00250</drugbank-id>
      <name>Dapsone</name>
      <description>The therapeutic efficacy of Dapsone can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00440</drugbank-id>
      <name>Trimethoprim</name>
      <description>The therapeutic efficacy of Trimethoprim can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00563</drugbank-id>
      <name>Methotrexate</name>
      <description>The therapeutic efficacy of Methotrexate can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00642</drugbank-id>
      <name>Pemetrexed</name>
      <description>The therapeutic efficacy of Pemetrexed can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01131</drugbank-id>
      <name>Proguanil</name>
      <description>The therapeutic efficacy of Proguanil can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01157</drugbank-id>
      <name>Trimetrexate</name>
      <description>The therapeutic efficacy of Trimetrexate can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03695</drugbank-id>
      <name>Piritrexim</name>
      <description>The therapeutic efficacy of Piritrexim can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04655</drugbank-id>
      <name>Metoprine</name>
      <description>The therapeutic efficacy of Metoprine can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06358</drugbank-id>
      <name>Iclaprim</name>
      <description>The therapeutic efficacy of Iclaprim can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06813</drugbank-id>
      <name>Pralatrexate</name>
      <description>The therapeutic efficacy of Pralatrexate can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08878</drugbank-id>
      <name>Aminopterin</name>
      <description>The therapeutic efficacy of Aminopterin can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12769</drugbank-id>
      <name>Lometrexol</name>
      <description>The therapeutic efficacy of Lometrexol can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12912</drugbank-id>
      <name>Nolatrexed</name>
      <description>The therapeutic efficacy of Nolatrexed can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13795</drugbank-id>
      <name>Brodimoprim</name>
      <description>The therapeutic efficacy of Brodimoprim can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB14763</drugbank-id>
      <name>Cycloguanil</name>
      <description>The therapeutic efficacy of Cycloguanil can be decreased when used in combination with (6R)-Folinic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00375</drugbank-id>
      <name>Colestipol</name>
      <description>The serum concentration of (6R)-Folinic acid can be decreased when it is combined with Colestipol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00544</drugbank-id>
      <name>Fluorouracil</name>
      <description>The risk or severity of adverse effects can be increased when (6R)-Folinic acid is combined with Fluorouracil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01099</drugbank-id>
      <name>Flucytosine</name>
      <description>The risk or severity of adverse effects can be increased when (6R)-Folinic acid is combined with Flucytosine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01101</drugbank-id>
      <name>Capecitabine</name>
      <description>The risk or severity of adverse effects can be increased when (6R)-Folinic acid is combined with Capecitabine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01629</drugbank-id>
      <name>5-fluorouridine</name>
      <description>The risk or severity of adverse effects can be increased when (6R)-Folinic acid is combined with 5-fluorouridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03419</drugbank-id>
      <name>Uracil</name>
      <description>The risk or severity of adverse effects can be increased when (6R)-Folinic acid is combined with Uracil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09256</drugbank-id>
      <name>Tegafur</name>
      <description>The risk or severity of adverse effects can be increased when (6R)-Folinic acid is combined with Tegafur.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12947</drugbank-id>
      <name>Doxifluridine</name>
      <description>The risk or severity of adverse effects can be increased when (6R)-Folinic acid is combined with Doxifluridine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00313</drugbank-id>
      <name>Valproic acid</name>
      <description>The serum concentration of (6R)-Folinic acid can be decreased when it is combined with Valproic acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00564</drugbank-id>
      <name>Carbamazepine</name>
      <description>The serum concentration of Carbamazepine can be decreased when it is combined with (6R)-Folinic acid.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-3.8</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(2S)-2-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]formamido}pentanedioic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-[(diaminomethylidene)amino]-1-oxopentan-2-yl]cyclopentanecarboxamide</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>473.4393</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>473.165896125</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>[H]N([H])C1=NC(=O)C2=C(N([H])C[C@@H](CN([H])C3=CC=C(C=C3)C(=O)N([H])[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1[H]</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C20H23N7O7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12-,13+/m1/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>VVIAGPKUTFNRDU-OLZOCXBDSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>215.55</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>126.46</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>44.63</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>12</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>3.21</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>4.66</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>135548</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46506235</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>119394</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>FON</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1232801</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0002961</id>
      <name>N,N-dimethylglycine oxidase</name>
      <organism>Arthrobacter globiformis</organism>
      <actions/>
      <references>
        <articles/>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9AGP8" source="Swiss-Prot">
        <name>Dimethylglycine oxidase</name>
        <general-function>Nucleotide binding</general-function>
        <specific-function>Catalyzes the oxidative demethylation of N,N-dimethylglycine to yield sarcosine, formaldehyde and hydrogen peroxide. The oxidation of dimethylglycine is coupled to the synthesis of 5,10-methylenetetrahydrofolate through an unusual substrate channeling mechanism. This channeling occurs by nonbiased diffusion of the iminium intermediate through a large solvent cavity connecting active site 1 (N-terminus) and active site 2 (C-terminus). The synthesis of 5,10-methylenetetrahydrofolate (at active site 2) prevents the accumulation of formaldehyde, formed by hydrolysis of the iminium intermediate product (at active site 1). Does not oxidize sarcosine.</specific-function>
        <gene-name>dmg</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.0</theoretical-pi>
        <molecular-weight>89983.935</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="1665">Arthrobacter globiformis</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF329477</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9AGP8</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>DMGO_ARTGO</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>1.5.3.10</synonym>
          <synonym>DMGO</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012081|Dimethylglycine oxidase
MASTPRIVIIGAGIVGTNLADELVTRGWNNITVLDQGPLNMPGGSTSHAPGLVFQTNPSK
TMASFAKYTVEKLLSLTEDGVSCFNQVGGLEVATTETRLADLKRKLGYAAAWGIEGRLLS
PAECQELYPLLDGENILGGLHVPSDGLASAARAVQLLIKRTESAGVTYRGSTTVTGIEQS
GGRVTGVQTADGVIPADIVVSCAGFWGAKIGAMIGMAVPLLPLAHQYVKTTPVPAQQGRN
DQPNGARLPILRHQDQDLYYREHGDRYGIGSYAHRPMPVDVDTLGAYAPETVSEHHMPSR
LDFTLEDFLPAWEATKQLLPALADSEIEDGFNGIFSFTPDGGPLLGESKELDGFYVAEAV
WVTHSAGVAKAMAELLTTGRSETDLGECDITRFEDVQLTPEYVSETSQQNFVEIYDVLHP
LQPRLSPRNLRVSPFHARHKELGAFFLEAGGWERPYWFEANAALLKEMPAEWLPPARDAW
SGMFSSPIAAAEAWKTRTAVAMYDMTPLKRLEVSGPGALKLLQELTTADLAKKPGAVTYT
LLLDHAGGVRSDITVARLSEDTFQLGANGNIDTAYFERAARHQTQSGSATDWVQVRDTTG
GTCCIGLWGPLARDLVSKVSDDDFTNDGLKYFRAKNVVIGGIPVTAMRLSYVGELGWELY
TSADNGQRLWDALWQAGQPFGVIAAGRAAFSSLRLEKGYRSWGTDMTTEHDPFEAGLGFA
VKMAKESFIGKGALEGRTEEASARRLRCLTIDDGRSIVLGKEPVFYKEQAVGYVTSAAYG
YTVAKPIAYSYLPGTVSVGDSVDIEYFGRRITATVTEDPLYDPKMTRLRG</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0005786|2493 bp
ATGGCATCGACGCCGCGTATTGTCATTATTGGAGCCGGCATTGTCGGTACGAACCTGGCC
GACGAGCTGGTCACCCGGGGCTGGAATAACATCACTGTCCTGGACCAGGGGCCTTTGAAT
ATGCCCGGCGGGTCCACGTCCCATGCCCCGGGCCTGGTTTTCCAGACCAACCCGTCCAAG
ACCATGGCCTCTTTCGCCAAGTACACGGTGGAGAAGCTGCTGTCGCTGACCGAGGACGGG
GTGAGCTGCTTCAACCAGGTCGGTGGCCTGGAAGTGGCCACCACCGAAACCCGCCTCGCT
GACCTGAAGCGCAAACTCGGCTACGCCGCCGCCTGGGGCATCGAAGGGCGCCTCCTGTCC
CCGGCCGAGTGCCAGGAGCTGTACCCGCTCCTGGACGGGGAAAACATCCTGGGCGGCCTC
CACGTGCCCAGCGATGGCCTGGCCAGCGCCGCCCGTGCGGTGCAGCTGCTGATCAAACGC
ACCGAGTCCGCCGGGGTCACATACCGCGGTTCGACCACCGTGACGGGCATTGAGCAGTCC
GGAGGCCGTGTCACGGGCGTGCAGACCGCCGACGGCGTGATCCCGGCCGATATCGTGGTG
TCCTGCGCCGGGTTCTGGGGCGCGAAGATCGGGGCCATGATCGGCATGGCCGTTCCCCTG
CTCCCGCTGGCCCACCAGTACGTAAAAACCACCCCGGTACCGGCGCAGCAGGGCAGGAAC
GACCAGCCGAACGGGGCCCGGCTGCCGATCCTGCGCCACCAGGACCAGGACCTCTACTAC
CGCGAACACGGGGACCGGTACGGCATCGGCTCCTACGCCCACCGGCCCATGCCCGTGGAC
GTCGACACCCTGGGGGCCTACGCGCCCGAGACCGTCAGCGAACACCACATGCCCTCCCGC
CTCGACTTCACCCTGGAGGACTTCCTGCCGGCGTGGGAGGCCACCAAGCAGCTCCTGCCC
GCGCTGGCGGACAGCGAGATCGAGGACGGCTTCAACGGCATCTTCTCCTTCACCCCCGAC
GGCGGGCCGCTCCTTGGCGAATCCAAGGAACTCGACGGCTTCTACGTCGCCGAAGCCGTC
TGGGTCACGCACTCCGCCGGCGTGGCCAAGGCCATGGCCGAACTGCTGACCACCGGCCGG
TCCGAGACCGACCTGGGCGAGTGCGACATCACCCGCTTCGAGGACGTCCAGCTCACCCCC
GAATACGTCAGCGAAACCTCACAGCAGAACTTCGTGGAAATCTACGACGTCCTGCACCCG
CTCCAGCCCAGACTCTCCCCCCGCAACCTGCGCGTGAGCCCCTTCCACGCCCGGCACAAA
GAACTCGGCGCGTTCTTCCTGGAAGCCGGCGGCTGGGAACGGCCCTACTGGTTCGAAGCC
AACGCCGCACTCCTCAAGGAGATGCCGGCCGAGTGGCTGCCGCCCGCACGCGACGCCTGG
TCCGGAATGTTCAGCTCCCCGATCGCCGCCGCCGAAGCCTGGAAAACCCGCACGGCCGTA
GCCATGTACGACATGACCCCGCTCAAGCGCCTCGAGGTCTCCGGCCCGGGGGCCCTCAAG
CTCCTGCAGGAACTGACGACGGCGGACCTGGCCAAGAAGCCGGGCGCGGTCACCTACACC
CTGCTGCTCGACCACGCCGGCGGCGTGCGAAGCGACATCACGGTGGCCCGCCTGAGCGAG
GACACCTTCCAGCTCGGCGCCAACGGCAACATCGACACCGCCTACTTCGAGCGGGCGGCC
CGGCACCAGACGCAAAGCGGATCCGCCACCGACTGGGTCCAGGTGCGCGACACCACCGGC
GGCACCTGCTGCATCGGCCTCTGGGGCCCGCTCGCCCGGGACCTCGTCAGCAAAGTCAGC
GACGACGACTTCACCAACGACGGCCTGAAGTACTTCCGGGCCAAGAACGTCGTCATCGGC
GGCATTCCCGTTACCGCCATGCGGCTTTCCTACGTCGGTGAACTCGGCTGGGAGCTGTAC
ACCAGCGCCGACAACGGACAGCGGCTGTGGGATGCGCTCTGGCAGGCAGGACAGCCCTTC
GGAGTCATCGCCGCCGGACGCGCGGCATTCAGCTCCCTGCGGCTCGAAAAGGGCTACCGC
TCCTGGGGAACCGACATGACCACGGAGCACGACCCCTTCGAAGCAGGGCTCGGATTCGCC
GTCAAGATGGCCAAGGAGAGCTTCATCGGCAAGGGCGCGCTCGAAGGCCGGACCGAAGAG
GCCTCCGCCCGCCGGCTGCGCTGCCTGACCATCGACGACGGCCGGTCCATCGTCCTCGGC
AAGGAACCCGTCTTCTACAAGGAACAGGCCGTCGGCTACGTCACCAGCGCCGCCTACGGG
TACACCGTGGCCAAACCCATCGCCTACTCCTACCTGCCGGGCACCGTCTCGGTCGGCGAC
TCCGTCGACATCGAATACTTCGGACGGCGCATCACCGCCACCGTCACAGAAGACCCGCTG
TACGACCCGAAAATGACCAGGCTCCGCGGCTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01571</identifier>
            <name>GCV_T</name>
          </pfam>
          <pfam>
            <identifier>PF01266</identifier>
            <name>DAO</name>
          </pfam>
          <pfam>
            <identifier>PF08669</identifier>
            <name>GCV_T_C</name>
          </pfam>
          <pfam>
            <identifier>PF16350</identifier>
            <name>FAO_M</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>dimethylglycine oxidase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>nucleotide binding</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001753</id>
      <name>Serine hydroxymethyltransferase</name>
      <organism>Geobacillus kaustophilus (strain HTA426)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q5KUI2" source="Swiss-Prot">
        <name>Serine hydroxymethyltransferase</name>
        <general-function>Pyridoxal phosphate binding</general-function>
        <specific-function>Catalyzes the reversible interconversion of serine and glycine with tetrahydrofolate (THF) serving as the one-carbon carrier. This reaction serves as the major source of one-carbon groups required for the biosynthesis of purines, thymidylate, methionine, and other important biomolecules. Also exhibits THF-independent aldolase activity toward beta-hydroxyamino acids, producing glycine and aldehydes, via a retro-aldol mechanism.</specific-function>
        <gene-name>glyA</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.24</theoretical-pi>
        <molecular-weight>45175.135</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="235909">Geobacillus kaustophilus (strain HTA426)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>BA000043</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>56381746</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q5KUI2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GLYA_GEOKA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.2.1</synonym>
          <synonym>SHMT</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016548|Serine hydroxymethyltransferase
MNYLPQQDPQVFAAIEQERKRQHAKIELIASENFVSRAVMEAQGSVLTNKYAEGYPGRRY
YGGCEYVDIVEDLARERAKQLFGAEHVNVQPHSGAQANMAVYFTVLEHGDTVLGMNLSHG
GHLTHGSPVNFSGIQYNFVEYGVDPETHVIDYDDVREKARLHRPKLIVAGASAYPRIIDF
AKFREIADEVGAYLMVDMAHIAGLVAAGVHPNPVPYAHFVTTTTHKTLRGPRGGMILCQE
QFAKQIDKAIFPGIQGGPLMHVIAAKAVALGEALQDDFKVYAKRVVENAKRLAAALQNEG
FTLISGGTDNHLLLVDLRPQQLTGKTAEKVLDEVGITVNKNTIPYDPESPFVTSGIRIGT
AAVTTRGFGLEEMDEIAAIIGLVLKNVGSEQALEEARQRVAALTEKFPLYQD</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0016549|Serine hydroxymethyltransferase (glyA)
ATGAATTACTTGCCACAACAAGATCCGCAAGTGTTCGCCGCTATTGAGCAAGAGCGGAAG
CGGCAACATGCGAAAATTGAACTGATCGCCTCGGAAAACTTTGTCAGCCGCGCGGTCATG
GAAGCGCAAGGGTCGGTGCTGACGAACAAATATGCGGAAGGCTATCCGGGACGCCGCTAC
TACGGCGGTTGTGAATATGTCGACATCGTCGAAGATTTGGCGCGCGAGCGAGCGAAGCAG
TTGTTTGGAGCGGAGCATGTGAACGTCCAGCCGCACTCCGGGGCGCAGGCGAACATGGCC
GTTTATTTCACCGTTCTTGAGCACGGCGACACGGTGCTTGGCATGAACTTGTCGCACGGC
GGCCATTTGACGCACGGCAGCCCGGTCAATTTCAGCGGCATTCAGTACAATTTTGTCGAA
TACGGCGTCGATCCGGAAACGCATGTCATTGACTATGACGACGTGCGCGAAAAAGCGCGC
CTTCACCGGCCGAAGTTGATCGTCGCCGGCGCGAGCGCCTATCCGCGCATCATCGACTTC
GCCAAGTTCCGCGAGATTGCCGATGAAGTCGGCGCCTATTTAATGGTTGACATGGCCCAT
ATTGCCGGTCTTGTTGCGGCAGGTGTTCATCCGAATCCAGTGCCGTACGCCCATTTCGTT
ACGACGACGACGCACAAAACGCTGCGCGGTCCGCGCGGCGGGATGATTTTATGCCAGGAG
CAGTTCGCCAAACAGATCGACAAAGCCATTTTCCCTGGCATTCAAGGCGGCCCGCTCATG
CATGTCATTGCCGCCAAAGCCGTCGCGCTCGGCGAAGCGTTGCAAGACGACTTTAAAGTC
TACGCGAAGCGCGTCGTGGAGAATGCCAAACGGCTCGCAGCCGCCTTGCAAAACGAAGGA
TTCACTCTCATTTCCGGCGGCACGGACAACCATTTGCTGCTTGTCGATTTGCGCCCGCAG
CAGCTGACCGGGAAAACGGCGGAGAAAGTGCTCGATGAGGTCGGGATTACGGTCAACAAA
AACACGATTCCGTACGATCCGGAAAGCCCGTTTGTCACAAGCGGCATCCGCATCGGCACG
GCCGCGGTCACGACGCGCGGCTTCGGATTGGAAGAGATGGACGAAATCGCCGCCATCATC
GGCCTTGTGCTGAAAAACGTCGGCAGCGAACAAGCGCTTGAGGAAGCGCGCCAACGCGTC
GCCGCTTTGACGGAAAAGTTTCCGCTCTATCAAGACTAA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00464</identifier>
            <name>SHMT</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glycine hydroxymethyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>pyridoxal phosphate binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine biosynthetic process from serine</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tetrahydrofolate interconversion</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001692</id>
      <name>Aminomethyltransferase</name>
      <organism>Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9WY54" source="Swiss-Prot">
        <name>Aminomethyltransferase</name>
        <general-function>Transaminase activity</general-function>
        <specific-function>The glycine cleavage system catalyzes the degradation of glycine.</specific-function>
        <gene-name>gcvT</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.23</theoretical-pi>
        <molecular-weight>40332.235</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="243274">Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AE000512</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>4980708</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q9WY54</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>GCST_THEMA</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.1.2.10</synonym>
          <synonym>Glycine cleavage system T protein</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019166|Aminomethyltransferase
MKRTPLFEKHVELGAKMVDFAGWEMPLYYTSIFEEVMAVRKSVGMFDVSHMGEFLVKGPE
AVSFIDFLITNDFSSLPDGKAIYSVMCNENGGIIDDLVVYKVSPDEALMVVNAANIEKDF
NWIKSHSKNFDVEVSNISDTTALIAFQGPKAQETLQELVEDGLEEIAYYSFRKSIVAGVE
TLVSRTGYTGEDGFELMLEAKNAPKVWDALMNLLRKIDGRPAGLGARDVCRLEATYLLYG
QDMDENTNPFEVGLSWVVKLNKDFVGKEALLKAKEKVERKLVALELSGKRIARKGYEVLK
NGERVGEITSGNFSPTLGKSIALALVSKSVKIGDQLGVVFPGGKLVEALVVKKPFYRGSV
RREV</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0019167|Aminomethyltransferase (gcvT)
ATGAAGAGAACGCCTCTATTTGAAAAGCATGTTGAACTCGGTGCGAAAATGGTAGATTTC
GCGGGGTGGGAGATGCCTCTTTATTACACATCCATATTCGAAGAAGTGATGGCAGTCAGA
AAATCGGTGGGGATGTTCGATGTCTCTCACATGGGGGAATTTCTCGTTAAAGGGCCCGAG
GCGGTTTCTTTTATTGACTTTCTTATAACGAACGACTTTTCTTCACTTCCGGATGGTAAA
GCGATTTACTCTGTCATGTGCAATGAAAACGGTGGAATCATCGATGATCTTGTTGTGTAC
AAGGTGAGTCCTGATGAAGCTCTCATGGTGGTGAACGCGGCAAACATTGAAAAGGACTTC
AACTGGATAAAATCCCATTCGAAGAATTTCGATGTCGAAGTATCGAACATTTCAGATACG
ACAGCGCTCATAGCGTTCCAGGGGCCAAAAGCACAGGAGACCCTCCAGGAGCTTGTTGAA
GACGGTCTCGAGGAAATTGCCTATTATTCTTTCAGAAAGAGTATTGTAGCCGGTGTAGAG
ACTCTTGTCTCAAGAACGGGATACACGGGTGAGGACGGTTTCGAACTGATGCTTGAAGCG
AAGAATGCACCGAAGGTCTGGGATGCTTTGATGAATCTGCTCAGAAAAATCGATGGCAGA
CCCGCAGGTCTTGGGGCGAGAGACGTTTGCCGACTCGAGGCGACTTATTTGCTGTACGGT
CAGGACATGGATGAGAACACGAATCCTTTCGAAGTGGGACTTTCCTGGGTTGTAAAACTG
AACAAAGACTTCGTGGGGAAGGAAGCGCTGCTGAAAGCGAAGGAAAAAGTGGAAAGAAAA
CTTGTGGCGCTTGAGCTCTCTGGAAAAAGAATAGCAAGAAAAGGCTATGAAGTTTTAAAG
AATGGAGAGAGAGTGGGAGAGATCACAAGTGGTAACTTCTCTCCAACTCTTGGGAAGTCG
ATAGCGCTGGCTCTCGTTTCAAAATCGGTGAAGATAGGAGACCAACTGGGAGTGGTGTTT
CCTGGTGGAAAGCTTGTAGAAGCTCTGGTAGTAAAAAAACCATTTTACAGAGGCAGTGTG
AGGAGGGAGGTTTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01571</identifier>
            <name>GCV_T</name>
          </pfam>
          <pfam>
            <identifier>PF08669</identifier>
            <name>GCV_T_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>aminomethyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transaminase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>glycine decarboxylation via glycine cleavage system</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0001788</id>
      <name>Bifunctional polymyxin resistance protein ArnA</name>
      <organism>Escherichia coli (strain K12)</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P77398" source="Swiss-Prot">
        <name>Bifunctional polymyxin resistance protein ArnA</name>
        <general-function>Udp-glucuronate decarboxylase activity</general-function>
        <specific-function>Bifunctional enzyme that catalyzes the oxidative decarboxylation of UDP-glucuronic acid (UDP-GlcUA) to UDP-4-keto-arabinose (UDP-Ara4O) and the addition of a formyl group to UDP-4-amino-4-deoxy-L-arabinose (UDP-L-Ara4N) to form UDP-L-4-formamido-arabinose (UDP-L-Ara4FN). The modified arabinose is attached to lipid A and is required for resistance to polymyxin and cationic antimicrobial peptides.</specific-function>
        <gene-name>arnA</gene-name>
        <locus/>
        <cellular-location/>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.86</theoretical-pi>
        <molecular-weight>74288.175</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="83333">Escherichia coli (strain K12)</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AY057445</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>16555376</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P77398</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ARNA_ECOLI</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>pmrI</synonym>
          <synonym>Polymyxin resistance protein PmrI</synonym>
          <synonym>yfbG</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011275|Bifunctional polymyxin resistance protein ArnA
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS
</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0011276|Bifunctional polymyxin resistance protein ArnA (arnA)
ATGAAAACCGTCGTTTTTGCCTACCACGATATGGGATGCCTCGGTATTGAAGCCCTGCTG
GCTGCCGGTTACGAAATTAGCGCCATTTTTACCCATACTGATAATCCCGGTGAAAAAGCC
TTTTATGGTTCGGTGGCTCGTCTGGCGGCGGAAAGAGGCATTCCGGTTTATGCGCCGGAT
AACGTTAATCATCCGCTGTGGGTGGAACGCATTGCCCAACTGTCGCCAGATGTGATTTTC
TCTTTTTATTATCGCCATCTTATTTACGACGAAATTTTGCAGCTCGCTCCCGCAGGTGCA
TTTAATCTGCATGGTTCGCTGTTACCAAAATATCGTGGTCGCGCGCCGCTGAACTGGGTG
CTGGTCAACGGTGAAACGGAAACTGGCGTTACATTGCACCGAATGGTGAAACGTGCCGAT
GCCGGGGCCATTGTGGCGCAACTGCGCATTGCCATTGCGCCAGACGATATCGCTATTACG
CTGCATCATAAATTGTGCCATGCCGCGCGCCAGCTACTGGAACAGACATTACCCGCCATT
AAACACGGTAATATTCTGGAAATCGCCCAGCGCGAAAACGAAGCCACCTGTTTTGGTCGC
AGAACGCCGGATGACAGTTTCCTTGAATGGCATAAACCGGCATCCGTACTGCACAACATG
GTACGTGCCGTTGCCGATCCGTGGCCGGGTGCCTTCAGCTATGTTGGCAATCAGAAATTC
ACCGTCTGGTCGTCGCGTGTTCATCCTCATGCCAGCAAAGCACAGCCGGGGAGCGTGATT
TCTGTTGCGCCACTGCTGATTGCCTGTGGCGATGGCGCGCTGGAAATCGTCACCGGACAG
GCGGGCGACGGCATTACTATGCAGGGCTCGCAATTAGCGCAGACGCTGGGCCTGGTGCAA
GGTTCACGCTTGAATAGCCAGCCTGCCTGCACCGCCCGACGCCGTACCCGGGTACTCATC
CTCGGGGTGAATGGCTTTATTGGCAACCATCTGACAGAACGCCTGCTGCGCGAAGATCAT
TATGAAGTTTACGGTCTGGATATTGGCAGCGATGCGATAAGCCGTTTTCTGAATCATCCG
CATTTTCACTTTGTTGAAGGCGATATCAGTATTCATTCCGAATGGATTGAGTATCATGTC
AAAAAATGTGATGTCGTCTTGCCGCTGGTGGCGATAGCCACGCCGATTGAATATACCCGC
AACCCGCTGCGCGTATTTGAACTCGATTTTGAAGAGAATCTGCGCATTATCCGCTACTGC
GTGAAGTACCGTAAGCGAATCATCTTCCCGTCAACTTCAGAAGTTTATGGGATGTGTAGC
GATAAATACTTCGATGAGGACCATTCTAATTTAATCGTCGGCCCGGTGAATAAACCACGC
TGGATTTATTCGGTATCAAAACAATTACTTGATCGGGTGATCTGGGCCTATGGCGAAAAA
GAGGGTTTACAGTTCACCCTCTTCCGCCCGTTTAACTGGATGGGACCACGACTGGATAAC
CTTAATGCAGCGCGAATTGGCAGCTCCCGCGCTATTACGCAACTCATTCTCAATCTGGTA
GAAGGTTCACCGATTAAGCTGATTGATGGCGGAAAACAAAAACGCTGCTTTACTGATATT
CGCGATGGTATCGAGGCGTTATACCGCATTATCGAAAATGCGGGAAATCGCTGCGACGGT
GAAATTATCAACATTGGCAATCCTGAGAACGAAGCGAGCATTGAGGAACTGGGCGAGATG
CTGCTGGCGAGCTTCGAAAAACATCCGCTGCGCCATCATTTCCCACCGTTTGCGGGCTTT
CGCGTTGTCGAAAGTAGCAGCTACTACGGCAAAGGATATCAGGACGTAGAGCATCGTAAA
CCGAGCATCCGCAATGCCCACCGCTGCCTGGACTGGGAGCCGAAAATTGATATGCAGGAA
ACCATCGACGAAACGCTGGATTTCTTCCTGCGCACCGTTGATCTTACGGATAAACCATCA
TGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF01370</identifier>
            <name>Epimerase</name>
          </pfam>
          <pfam>
            <identifier>PF00551</identifier>
            <name>Formyl_trans_N</name>
          </pfam>
          <pfam>
            <identifier>PF02911</identifier>
            <name>Formyl_trans_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>function</category>
            <description>hydroxymethyl-, formyl- and related transferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>NAD+ binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>UDP-glucuronate decarboxylase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lipid A biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lipopolysaccharide biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to antibiotic</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>UDP-D-xylose biosynthetic process</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target>
      <id>BE0000822</id>
      <name>Formimidoyltransferase-cyclodeaminase</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <ref-id>A1991</ref-id>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O95954" source="Swiss-Prot">
        <name>Formimidoyltransferase-cyclodeaminase</name>
        <general-function>Microtubule binding</general-function>
        <specific-function>Folate-dependent enzyme, that displays both transferase and deaminase activity. Serves to channel one-carbon units from formiminoglutamate to the folate pool.Binds and promotes bundling of vimentin filaments originating from the Golgi.</specific-function>
        <gene-name>FTCD</gene-name>
        <locus/>
        <cellular-location>Cytoplasm</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>5.45</theoretical-pi>
        <molecular-weight>58925.93</molecular-weight>
        <chromosome-location>21</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:3974</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>FTCD</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AF169017</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>6537208</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>O95954</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>FTCD_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>Formiminotransferase-cyclodeaminase</synonym>
          <synonym>FTCD</synonym>
          <synonym>LCHC1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001640|Formimidoyltransferase-cyclodeaminase
MSQLVECVPNFSEGKNQEVIDAISGAITQTPGCVLLDVDAGPSTNRTVYTFVGPPECVVE
GALNAARVASRLIDMSRHQGEHPRMGALDVCPFIPVRGVSVDECVLCAQAFGQRLAEELD
VPVYLYGEAARMDSRRTLPAIRAGEYEALPKKLQQADWAPDFGPSSFVPSWGATATGARK
FLIAFNINLLGTKEQAHRIALNLREQGRGKDQPGRLKKVQGIGWYLDEKNLAQVSTNLLD
FEVTALHTVYEETCREAQELSLPVVGSQLVGLVPLKALLDAAAFYCEKENLFILEEEQRI
RLVVSRLGLDSLCPFSPKERIIEYLVPERGPERGLGSKSLRAFVGEVGARSAAPGGGSVA
AAAAAMGAALGSMVGLMTYGRRQFQSLDTTMRRLIPPFREASAKLTTLVDADAEAFTAYL
EAMRLPKNTPEEKDRRTAALQEGLRRAVSVPLTLAETVASLWPALQELARCGNLACRSDL
QVAAKALEMGVFGAYFNVLINLRDITDEAFKDQIHHRVSSLLQEAKTQAALVLDCLETRQ
E</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0019016|Formimidoyltransferase-cyclodeaminase (FTCD)
ATGTCCCAGCTGGTGGAATGCGTCCCCAACTTTTCGGAGGGGAAGAACCAGGAGGTGATC
GACGCCATCTCTGGAGCCATCACACAGACCCCGGGCTGCGTGCTGCTGGATGTGGACGCA
GGCCCTTCCACCAACCGCACCGTGTACACCTTCGTGGGGCCGCCGGAGTGCGTGGTGGAG
GGGGCCCTCAACGCTGCCCGGGTAGCTTCCCGACTTATCGACATGAGCAGGCACCAAGGA
GAGCACCCCCGCATGGGGGCCCTAGACGTCTGCCCCTTCATCCCCGTGAGGGGCGTCAGC
GTGGATGAGTGTGTGCTCTGCGCCCAGGCCTTTGGCCAGAGGCTGGCAGAGGAGCTGGAC
GTGCCAGTTTACCTGTACGGCGAGGCAGCCAGGATGGACAGTCGCCGGACCCTGCCGGCC
ATCCGGGCCGGGGAGTACGAGGCCCTCCCTAAGAAGCTCCAGCAGGCCGACTGGGCGCCC
GACTTTGGTCCCAGCTCCTTTGTCCCCAGTTGGGGGGCCACGGCCACGGGGGCGAGGAAG
TTCCTCATTGCTTTTAACATCAACCTGCTCGGCACAAAGGAGCAAGCCCACCGCATCGCG
CTCAACCTGCGGGAGCAGGGCCGCGGGAAGGACCAGCCAGGACGTCTGAAGAAAGTTCAG
GGCATTGGCTGGTACCTGGATGAGAAGAACCTGGCTCAGGTGTCCACCAATCTTCTGGAC
TTTGAGGTCACGGCACTGCACACGGTCTACGAGGAGACCTGCCGAGAAGCACAGGAGCTG
AGCCTCCCAGTGGTGGGCTCACAGCTGGTGGGCCTGGTGCCCCTGAAGGCTCTGCTGGAT
GCGGCCGCCTTCTACTGCGAGAAGGAGAACCTCTTCATCCTGGAGGAGGAGCAGCGGATC
AGGCTGGTGGTGAGCCGGCTGGGCCTGGACTCCCTGTGCCCCTTCAGCCCTAAGGAGCGG
ATCATCGAGTACCTGGTCCCTGAGCGCGGGCCTGAGCGAGGCCTGGGCAGCAAGTCCCTG
CGCGCCTTCGTGGGGGAGGTGGGTGCCCGCTCTGCGGCCCCCGGGGGCGGCTCGGTGGCG
GCGGCCGCTGCGGCCATGGGTGCGGCGCTGGGCTCCATGGTGGGCCTCATGACCTACGGG
CGGCGCCAATTCCAGTCCCTGGACACGACGATGCGGCGCCTGATCCCGCCCTTCCGCGAG
GCTTCGGCCAAGCTAACCACGCTGGTGGATGCCGACGCCGAGGCCTTCACCGCCTACCTG
GAAGCAATGAGGCTCCCCAAGAACACACCTGAGGAAAAGGACAGGCGCACGGCGGCCCTA
CAGGAGGGTCTGAGGCGGGCAGTCTCTGTGCCGCTGACGCTGGCGGAGACGGTGGCCTCG
CTGTGGCCGGCCCTGCAGGAACTGGCCCGGTGTGGGAACCTGGCCTGCCGGTCAGACCTC
CAGGTGGCGGCCAAAGCCCTGGAGATGGGCGTGTTTGGCGCATATTTCAACGTGCTCATC
AACCTGAGGGACATCACAGACGAGGCATTTAAGGACCAGATCCACCATCGTGTTTCCAGC
CTCCTGCAGGAAGCCAAGACCCAGGCTGCACTGGTGCTGGACTGCTTGGAGACCCGGCAG
GAGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF04961</identifier>
            <name>FTCD_C</name>
          </pfam>
          <pfam>
            <identifier>PF07837</identifier>
            <name>FTCD_N</name>
          </pfam>
          <pfam>
            <identifier>PF02971</identifier>
            <name>FTCD</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>centriole</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endoplasmic reticulum</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>endoplasmic reticulum-Golgi intermediate compartment</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>extracellular exosome</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>Golgi apparatus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>Golgi membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>smooth endoplasmic reticulum membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>folic acid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>formimidoyltetrahydrofolate cyclodeaminase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>formimidoyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>glutamate formimidoyltransferase activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>microtubule binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular nitrogen compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cytoskeleton organization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>folic acid-containing compound metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>histidine catabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>histidine catabolic process to glutamate and formamide</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>histidine catabolic process to glutamate and formate</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small molecule metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tetrahydrofolate interconversion</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>